Minerva Surgical, Inc.
NASDAQ:UTRS
0.0001 (USD) • At close January 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11.965 | 13.391 | 12.533 | 13.804 | 12.588 | 12.967 | 10.935 | 13.645 | 12.506 | 14.114 | 11.838 | 13.549 | 12.28 |
| Cost of Revenue
| 5.747 | 5.989 | 5.518 | 6.433 | 5.775 | 5.322 | 5.522 | 5.82 | 5.373 | 5.382 | 5.005 | 5.364 | 5.725 |
| Gross Profit
| 6.218 | 7.402 | 7.015 | 7.371 | 6.813 | 7.645 | 5.413 | 7.825 | 7.133 | 8.732 | 6.833 | 8.185 | 6.555 |
| Gross Profit Ratio
| 0.52 | 0.553 | 0.56 | 0.534 | 0.541 | 0.59 | 0.495 | 0.573 | 0.57 | 0.619 | 0.577 | 0.604 | 0.534 |
| Reseach & Development Expenses
| 1.413 | 1.477 | 1.765 | 1.458 | 1.456 | 1.274 | 1.255 | 1.101 | 1.367 | 1.673 | 1.151 | 1.173 | 1.2 |
| General & Administrative Expenses
| 4.19 | 4.222 | 5.358 | 1.664 | 6.142 | 1.579 | 4.985 | 4.068 | 3.987 | 10.125 | 4.003 | 2.324 | 1.804 |
| Selling & Marketing Expenses
| 6.711 | 9.361 | 10.202 | 9.441 | 9.723 | 9.691 | 9.473 | 9.31 | 7.919 | 8.497 | 6.469 | 6.769 | 6.722 |
| SG&A
| 10.901 | 13.583 | 15.56 | 11.105 | 15.865 | 11.27 | 14.458 | 13.378 | 11.906 | 18.622 | 10.472 | 9.093 | 8.526 |
| Other Expenses
| 0 | -0.002 | -0.003 | -0.035 | -0.002 | -0.03 | -0.002 | 0.204 | -0.004 | 0.048 | -0.587 | -0.004 | -0.001 |
| Operating Expenses
| 12.314 | 15.06 | 17.325 | 12.563 | 17.321 | 12.544 | 15.713 | 14.479 | 13.273 | 20.295 | 11.623 | 10.266 | 9.726 |
| Operating Income
| -6.096 | -7.658 | -10.31 | -5.192 | -10.508 | -4.899 | -10.3 | -6.654 | -6.14 | -11.563 | -4.79 | -2.081 | -3.171 |
| Operating Income Ratio
| -0.509 | -0.572 | -0.823 | -0.376 | -0.835 | -0.378 | -0.942 | -0.488 | -0.491 | -0.819 | -0.405 | -0.154 | -0.258 |
| Total Other Income Expenses Net
| -1.082 | -0.984 | -1.033 | -1.042 | -0.821 | -0.714 | -0.625 | 17.471 | 2.915 | -2.536 | -10.158 | -4.29 | -4.153 |
| Income Before Tax
| -7.178 | -8.642 | -11.343 | -6.234 | -11.329 | -5.613 | -10.925 | 10.817 | -3.225 | -14.099 | -14.948 | -6.371 | -7.324 |
| Income Before Tax Ratio
| -0.6 | -0.645 | -0.905 | -0.452 | -0.9 | -0.433 | -0.999 | 0.793 | -0.258 | -0.999 | -1.263 | -0.47 | -0.596 |
| Income Tax Expense
| 0.003 | 0.039 | 2.101 | 0.011 | 0.859 | 0.714 | 0.625 | 0.009 | 0.993 | 3.649 | 2.864 | 3.422 | 3.292 |
| Net Income
| -7.181 | -8.681 | -13.444 | -6.245 | -11.329 | -6.327 | -11.55 | 10.808 | -3.225 | -14.099 | -14.948 | -6.371 | -7.324 |
| Net Income Ratio
| -0.6 | -0.648 | -1.073 | -0.452 | -0.9 | -0.488 | -1.056 | 0.792 | -0.258 | -0.999 | -1.263 | -0.47 | -0.596 |
| EPS
| -0.81 | -0.98 | -2.81 | -0.21 | -7.92 | -4.43 | -8.11 | 7.5 | -2.26 | -13.82 | -14.66 | -0.31 | -7.18 |
| EPS Diluted
| -0.81 | -0.98 | -2.81 | -0.21 | -7.92 | -4.43 | -8.11 | 7.5 | -2.26 | -13.82 | -14.66 | -0.31 | -7.18 |
| EBITDA
| -4.56 | -5.53 | -10.275 | -5.208 | -7.776 | -2.217 | -7.625 | -6.44 | -6.144 | -8.824 | -2.733 | 0.577 | -0.618 |
| EBITDA Ratio
| -0.381 | -0.413 | -0.82 | -0.377 | -0.618 | -0.171 | -0.697 | -0.472 | -0.491 | -0.625 | -0.231 | 0.043 | -0.05 |